Amrize Ltd (NYSE:AMRZ – Get Free Report) has been assigned an average rating of “Hold” from the nineteen analysts that are currently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $47.65.
A number of research firms have weighed in on AMRZ. Royal Bank Of Canada decreased their target price on shares of Amrize from $48.00 to $32.00 and set an “underperform” rating on the stock in a research note on Friday, October 9th. Citigroup dropped their price target on Amrize from $58.00 to $50.00 and set a “buy” rating for the company in a research note on Friday, October 2nd. Truist Financial cut their price objective on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. Berenberg Bank lowered Amrize from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $48.00 to $46.00 in a research report on Monday. Finally, Wall Street Zen lowered Amrize from a “hold” rating to a “sell” rating in a research report on Saturday.
Check Out Our Latest Report on Amrize
Amrize Price Performance
AMRZ stock opened at $41.96 on Wednesday. The company has a 50 day simple moving average of $39.46 and a 200 day simple moving average of $50.18. The stock has a market cap of $23.21 billion, a price-to-earnings ratio of 18.99, a P/E/G ratio of 1.68 and a beta of 0.04. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67.
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting the consensus estimate of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The business had revenue of $3.77 billion during the quarter. During the same period in the previous year, the company earned $0.98 EPS. Amrize’s revenue for the quarter was up 2.6% on a year-over-year basis. Research analysts anticipate that Amrize will post 2.30 EPS for the current fiscal year.
Amrize Dividend Announcement
The company also recently announced a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be given a $0.11 dividend. The ex-dividend date is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is currently 4.98%.
Insider Transactions at Amrize
In other news, Director Jacques Sanche acquired 4,150 shares of the stock in a transaction dated Wednesday, August 26th. The stock was bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares of the company’s stock, valued at $439,665.32. This represents a 73.90% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jan Jenisch acquired 4,000 shares of the stock in a transaction dated Wednesday, September 2nd. The stock was purchased at an average cost of $42.50 per share, with a total value of $170,000.00. Following the purchase, the chief executive officer directly owned 519,000 shares of the company’s stock, valued at $22,057,500. This trade represents a 0.78% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 34,155 shares of company stock worth $1,461,276 over the last three months. Insiders own 0.54% of the company’s stock.
Institutional Investors Weigh In On Amrize
A number of institutional investors have recently added to or reduced their stakes in AMRZ. Private Advisor Group LLC raised its stake in shares of Amrize by 14.3% during the third quarter. Private Advisor Group LLC now owns 9,460 shares of the company’s stock valued at $354,000 after acquiring an additional 1,187 shares during the last quarter. Ieq Capital LLC grew its stake in shares of Amrize by 802.9% in the third quarter. Ieq Capital LLC now owns 69,649 shares of the company’s stock worth $2,604,000 after purchasing an additional 61,935 shares during the last quarter. Rothschild Investment LLC grew its stake in shares of Amrize by 5.3% in the third quarter. Rothschild Investment LLC now owns 7,876 shares of the company’s stock worth $294,000 after purchasing an additional 395 shares during the last quarter. Banco Santander S.A. increased its holdings in Amrize by 13.9% in the third quarter. Banco Santander S.A. now owns 10,091 shares of the company’s stock valued at $377,000 after purchasing an additional 1,232 shares during the period. Finally, Alberta Investment Management Corp increased its holdings in Amrize by 8.0% in the third quarter. Alberta Investment Management Corp now owns 253,600 shares of the company’s stock valued at $9,482,000 after purchasing an additional 18,800 shares during the period.
Amrize Company Profile
Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.
Featured Stories
- Five stocks we like better than Amrize
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
